biosimilar portfolio

Prestige Biopharma, a South Korean biopharmaceutical developer, said on Tuesday that the final analysis of phase 3 clinical trial on the anti-cancer...

Celltrion Healthcare Co. Ltd. said on Thursday that it launched Vegzelma, a biosimilar to the anti-cancer drug Avastin (active ingredient: bevacizum...

South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...

Carrier Global Corp.’s joint venture in South Korea aims to ramp up sales with the cold chain business, the series of actions and equipment ap...

South Korea's Celltrion Healthcare Co. on Tuesday said that for the second straight year, it landed an order for infliximab, an antibody used to tre...

South Korea's biosimilar heavyweight Celltrion Inc. has obtained permission from the Canadian health ministry to sell anticancer biosimilar Vegzelma...

SK Chemicals said on Monday that it is strengthening its portfolio of neurological diseases by introducing Tiglutik (riluzole), Lou Gehrig's disease...

South Korea's bio company Alteogen Inc. on Friday said it signed its fourth technology export contract since its 2018 development of the human recom...

The TIGER KEDI30 ETF has topped the list of the most purchased exchange-traded funds (ETFs) by South Korea’s individual investors in the theme...

SK Inc., the holding company of South Korea’s No. 2 conglomerate SK Group, has expanded its sustainable food business by investing in a US-bas...

South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...

South Korean private equity (PE) firms are having trouble fundraising as institutional investors' capital for new investment is drying up amid inter...

Korea Post’s insurance bureau will maintain its core-satellite strategy in private equity and debt investments for both stable revenue streams...

Celltrion Inc., South Korea’s biopharmaceutical giant, made a foray into the digital healthcare sector for its future growth by launching a sm...

Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...

South Korea’s top mobile carrier SK Telecom Co. is expanding its business portfolio with quantum technology, even into industries that are unr...

The Korea Economic Daily (KED) is hosting a global financial conference for Korean investors in the heart of New York City in October, where top Wal...

The National Pension Service (NPS) of South Korea, has committed capital to Blackstone Credit’s Sustainable Resources Platform to enhance the ...

Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...

Harim Co., South Korea’s top poultry processing company, is seeking to acquire Genofocus Inc., a Kosdaq-listed industrial and pharmaceutical e...

South Korea’s biopharmaceutical maker Celltrion Inc. on Friday reported strong quarterly earnings thanks to healthy demand for its biosimilar ...

SK E&S Co., the natural gas business unit of South Korea’s SK Group, said on Monday it is set to invest $25 million in US turquoise hydrog...

NEW YORK – Samsung Bioepis Co., a biopharmaceutical unit of South Korea’s top conglomerate Samsung, is one step ahead of its rivals in t...

South Korea’s two major biopharmaceutical companies, Celltrion Inc. and Samsung Biologics Co., are respectively expecting more than 2 trillion...

LG Electronics Inc., in partnership with GS Group, is advancing into the electric vehicle charging service market by acquiring AppleMango Co., a Sou...

SK Innovation Co. announced Tuesday it will inject $30 million into Brooklyn-based Amogy Inc. The intermediate holding company of SK Group and ...

Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said its SB12, a proposed biosimilar to Alexion Pharmaceuticals Inc.’s rare bl...

Dubai’s sovereign wealth fund is discussing the sale of Ssangyong Engineering & Construction Co. to a South Korean textile business group....

South Korea's biopharmaceutical company Celltrion Inc. plans to sell all of its biosimilar products through its own sales channels in Europe to impr...

It seems as though the list of risks to investors is rising. Supply chain imbalances, higher raw material costs, rising interest rates, labor shortage...